Do you dose ESAs via an intravenous or subcutaneous route for hospitalized patients with ESKD and anemia?

ESAs are dosed IV at our hospital. No good reason aside from patient comfort probably. I personally think giving ESAs to hospitalized patients is largely a waste due to their inflammation, infection, etc.

Barring any other contraindications, I generally prefer the intravenous route to avoid the unnecessary pain associated with subcutaneous injections. Regardless of the route, these patients will likely receive ESAs once or twice during their hospital stay, so the choice of administration method won’t...